These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20225292)

  • 1. Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction.
    van der Mei IA; Ponsonby AL; Taylor BV; Stankovich J; Dickinson JL; Foote S; Kemp A; Dwyer T
    Ann Neurol; 2010 Feb; 67(2):261-5. PubMed ID: 20225292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
    Hedström AK; Sundqvist E; Bäärnhielm M; Nordin N; Hillert J; Kockum I; Olsson T; Alfredsson L
    Brain; 2011 Mar; 134(Pt 3):653-64. PubMed ID: 21303861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction.
    Ramagopalan SV; Dyment DA; Giovannoni G; Sadovnick AD; Ebers GC
    Ann Neurol; 2010 May; 67(5):694-5. PubMed ID: 20437569
    [No Abstract]   [Full Text] [Related]  

  • 4. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
    Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
    Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
    Wu JS; James I; Qiu W; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    J Neuroimmunol; 2010 Feb; 219(1-2):109-13. PubMed ID: 20006387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pars planitis: clinical features and class II HLA associations.
    Raja SC; Jabs DA; Dunn JP; Fekrat S; Machan CH; Marsh MJ; Bressler NM
    Ophthalmology; 1999 Mar; 106(3):594-9. PubMed ID: 10080220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
    Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
    Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
    Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.